Patents-Review.com
🔗 Permalink
Assignee profile:

OPKO CURNA LLC

City:

MIAMI, Florida

Country:

United States

Published Applications:

19

Last publication date:

2012-10-04

Patent Grants:

13

Last grant date:

2016-01-12

Top Inventors for applications by OPKO CURNA LLC

These are the the leading inventors for applications assigned to OPKO CURNA LLC:

Recent patent applications by OPKO CURNA LLC

OPKO CURNA LLC based in MIAMI, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-10-04
US20120252869A1
Chemistry; metallurgy

TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)

 #2 | 2012-07-05
US20120171170A1
Chemistry; metallurgy

TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE

 #3 | 2012-06-14 ✅ Patent 9,234,199 granted on 2016-01-12
US20120149759A1
Chemistry; metallurgy

Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)

 #4 | 2012-06-07 ✅ Patent 8,921,330 granted on 2014-12-30
US20120142758A1
Chemistry; metallurgy

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

 #5 | 2012-06-07 ✅ Patent 9,023,822 granted on 2015-05-05
US20120142610A1
Chemistry; metallurgy

Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP

 #6 | 2012-05-24 ✅ Patent 9,044,493 granted on 2015-06-02
US20120129917A1
Chemistry; metallurgy

Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin

 #7 | 2012-04-19 ✅ Patent 8,895,527 granted on 2014-11-25
US20120095079A1
Chemistry; metallurgy

Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3

 #8 | 2012-04-19 ✅ Patent 8,859,515 granted on 2014-10-14
US20120094934A1
Chemistry; metallurgy

Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2

 #9 | 2012-04-12 ✅ Patent 8,791,085 granted on 2014-07-29
US20120088817A1
Chemistry; metallurgy

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

 #10 | 2012-03-15 ✅ Patent 8,957,037 granted on 2015-02-17
US20120064048A1
Chemistry; metallurgy

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

 #11 | 2012-02-23 ✅ Patent 9,012,139 granted on 2015-04-21
US20120046345A1
Human necessities

Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family

 #12 | 2012-02-23
US20120046236A1
Chemistry; metallurgy

TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP

 #13 | 2011-12-29 ✅ Patent 9,074,210 granted on 2015-07-07
US20110319475A1
Chemistry; metallurgy

Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF

 #14 | 2011-12-29
US20110319317A1
Chemistry; metallurgy

TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1

 #15 | 2011-12-01
US20110294870A1
Chemistry; metallurgy

TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENE

 #16 | 2011-09-29 ✅ Patent 8,921,329 granted on 2014-12-30
US20110237651A1
Chemistry; metallurgy

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

 #17 | 2011-09-29 ✅ Patent 8,927,511 granted on 2015-01-06
US20110237650A1
Chemistry; metallurgy

Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF

 #18 | 2011-09-29
US20110237649A1
Human necessities

TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN 1

 #19 | 2010-04-29 ✅ Patent 8,153,606 granted on 2012-04-10
US20100105760A1
Chemistry; metallurgy

Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1
AssigneeID:

177061 ⎘